Instil Bio (TIL) vs Tevogen (TVGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Instil Bio (TIL) has outperformed Tevogen (TVGN) over the past year, losing 62.9% versus a loss of 82.5%. Instil Bio is the larger company by market cap ($44.5 million vs $40.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TIL | TVGN |
|---|---|---|
| Share price | $6.56 | $6.23 |
| Market cap | $44.49M | $40.57M |
| 1-day change | -4.23% | -4.01% |
| YTD return | -37.27% | -60.79% |
| 1-year return | -62.86% | -82.51% |
| 5-year return | -98.07% | — |
| EPS (TTM) | $-4.43 | $-6.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $21.98 | $39.00 |
| 52-week low | $5.67 | $3.64 |
| Distance from 52-week high | -70.15% | -84.03% |
| Average volume | 11.93K | 9.75K |
| Shares outstanding | 6.78M | 6.51M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TIL has outperformed TVGN by 19.6 percentage points over the past year.
TIL vs TVGN FAQ
Which is bigger, Instil Bio or Tevogen?
Instil Bio (TIL) is larger, with a market capitalization of $44.49M compared with $40.57M for Tevogen (TVGN).
Which stock has performed better over the past year, TIL or TVGN?
TIL returned -62.86% over the past 12 months, compared with -82.51% for TVGN (price return, excluding dividends). Past performance does not predict future results.
Are Instil Bio and Tevogen in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.